These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 37835420)

  • 41. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
    Tsochatzis EA; Germani G; Burroughs AK
    Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization and radioembolization: a retrospective study.
    Jeliazkova P; Umgelter A; Braren R; Kaissis G; Mustafa M; Einwächter H
    Eur J Gastroenterol Hepatol; 2020 Aug; 32(8):1036-1041. PubMed ID: 31851090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Embolization of liver tumors: Past, present and future.
    Rammohan A; Sathyanesan J; Ramaswami S; Lakshmanan A; Senthil-Kumar P; Srinivasan UP; Ramasamy R; Ravichandran P
    World J Radiol; 2012 Sep; 4(9):405-12. PubMed ID: 23024842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
    Li J; Wang Q; Lei Z; Wu D; Si A; Wang K; Wan X; Wang Y; Yan Z; Xia Y; Lau WY; Wu M; Shen F
    Oncologist; 2015 Jun; 20(6):640-7. PubMed ID: 25956404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver-Directed Treatment Options Following Liver Tumor Recurrence: A Review of the Literature.
    Aquina CT; Eskander MF; Pawlik TM
    Front Oncol; 2022; 12():832405. PubMed ID: 35174097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conventional and drug-eluting beads transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a systematic review and pooled analysis.
    He M; Jiang N; Yin X; Xu A; Mu K
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):531-540. PubMed ID: 36402872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrahepatic Cholangiocarcinoma: A Summative Review of Biomarkers and Targeted Therapies.
    Acher AW; Paro A; Elfadaly A; Tsilimigras D; Pawlik TM
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma.
    Auer TA; Collettini F; Segger L; Pelzer U; Mohr R; Krenzien F; Gebauer B; Geisel D; Hosse C; Schöning W; Fehrenbach U
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Yttrium-90 microsphere selective internal radiation therapy for liver metastases following systemic chemotherapy and surgical resection for metastatic adrenocortical carcinoma.
    Makary MS; Krishner LS; Wuthrick EJ; Bloomston MP; Dowell JD
    World J Clin Oncol; 2018 Feb; 9(1):20-25. PubMed ID: 29468134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful Transcatheter Arterial Radioembolization of Hepatocellular Carcinoma Via Left Internal Mammary Artery: A Case Report.
    Alhussaini A; Qazi SA; AlZahrani YA
    Cureus; 2022 Mar; 14(3):e22954. PubMed ID: 35411262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current management of intrahepatic cholangiocarcinoma: from resection to palliative treatments.
    Bartolini I; Risaliti M; Fortuna L; Agostini C; Ringressi MN; Taddei A; Muiesan P
    Radiol Oncol; 2020 Jul; 54(3):263-271. PubMed ID: 32726292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transvascular therapy of Hepatocellular Carcinoma (HCC), status and developments.
    Gnutzmann D; Kortes N; Sumkauskaite M; Schmitz A; Weiss KH; Radeleff B
    Minim Invasive Ther Allied Technol; 2018 Apr; 27(2):69-80. PubMed ID: 29381102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Radioembolization for Biliary Tract and Primary Liver Cancer.
    Taylor AC; Maddirela D; White SB
    Surg Oncol Clin N Am; 2019 Oct; 28(4):731-743. PubMed ID: 31472916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on Embolization Therapies for Hepatocellular Carcinoma.
    Kishore S; Friedman T; Madoff DC
    Curr Oncol Rep; 2017 Jun; 19(6):40. PubMed ID: 28421483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility Study.
    Kis B; Shridhar R; Mhaskar R; Gyano M; Frakes JM; El-Haddad G; Choi J; Kim RD; Hoffe SE
    J Vasc Interv Radiol; 2023 Sep; 34(9):1547-1555. PubMed ID: 37210030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies.
    Makary MS; Khandpur U; Cloyd JM; Mumtaz K; Dowell JD
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radioembolization of Intrahepatic Cholangiocarcinoma: Patient Selection, Outcomes, and Competing Therapies.
    Ness JR; Molvar C
    Semin Intervent Radiol; 2021 Oct; 38(4):438-444. PubMed ID: 34629711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Locoregional options in the management of cholangiocarcinoma: single center experience.
    Baydoun H; Meirovich H; Maroun G; Coburn N; David E
    Ann Palliat Med; 2021 Feb; 10(2):1784-1791. PubMed ID: 33725764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Locoregional therapies in cholangiocarcinoma.
    Labib PL; Davidson BR; Sharma RA; Pereira SP
    Hepat Oncol; 2017 Oct; 4(4):99-109. PubMed ID: 29367874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrahepatic cholangiocarcinoma.
    Poultsides GA; Zhu AX; Choti MA; Pawlik TM
    Surg Clin North Am; 2010 Aug; 90(4):817-37. PubMed ID: 20637950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.